HealthCare Middle East & Africa Magazine News-WEEK3
HealthCare Middle East & Africa Magazine
No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
AFRICAN ?NEWS HEADLINES
Dr. Kalebi Labs earns ISO15189 accreditation in record time
KENYA—?Dr. Kalebi Labs (DKL) has announced that it has officially received ISO 15189 certification from the Kenya National Accreditation Service (KENAS), effective December 20, 2024. . .?More
South Sudan launches cholera vaccination campaign in Unity State
SOUTH SUDAN—South Sudan has intensified efforts to combat the ongoing cholera outbreak by launching a vaccination campaign targeting over 300,000 people in Rubkona County, Unity State. . . More
Rwanda introduces new anti-malaria drugs to combat resistance
RWANDA —The Rwanda Biomedical Centre (RBC) has announced plans to deploy two new anti-malaria drugs as part of efforts to tackle increasing resistance to existing treatments. . .More
Egyptian Drug Authority earns WHO ML3 in pharmaceutical regulation
?EGYPT—The Egyptian Drug Authority (EDA) has earned the World Health Organisation’s (WHO) Maturity Level 3 (ML3) designation for medicines regulation. . .More
MIDDLE EAST NEWS HEADLINES
M42’s IROS partners with Halia Therapeutics to launch clinical study on obesity treatment in UAE
UAE— IROS, an Abu Dhabi-based contract research organization has partnered with Halia Therapeutics to conduct a pioneering clinical trial focused on obesity treatment. . . More
领英推荐
King Faisal Specialist Hospital and Research Centre in Madinah earns prestigious ISO certification
SAUDI ARABIA—King Faisal Specialist Hospital and Research Centre (KFSHRC) in Madinah has recently earned the ISO 41001:2018 certification for Facility Management. . .More
CellSave Arabia introduces Adult Stem Cell Storage
UAE—CellSave?Arabia, a trusted leader in newborn stem cell banking since 2005 and part of the CSG BIO Group, is set to launch its adult stem cell storage services in 2025. . .More
WORLD NEWS HEADLINES
Chugai, Araris forge US$780M collaboration to advance antibody-drug conjugates
GLOBAL— Chugai Pharmaceutical and Araris Biotech have announced a research collaboration and option-to-license agreement centred on antibody-drug conjugates (ADCs) valued at up to US$780 million. . .More
Candid Therapeutics licenses novel TCE from WuXi Biologics
USA—US-based Candid Therapeutics has signed a new partnership with Chinese biotech company WuXi Biologics, gaining exclusive global rights to a promising preclinical asset. . .More
WHO prequalifies first diagnostic test for G6PD deficiency
SWITZERLAND—The World Health Organization (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. . .More
This is an exciting time for healthcare advancements! The collaboration between AI and human expertise is set to revolutionize patient care and research. Kudos to all the organizations driving these innovations forward!